Table 5.
Adverse Events | Histology | Total | <30 Years | 30–59 Years | ≥60 Years | p |
---|---|---|---|---|---|---|
Steroid-induced diabetes | MCD | 11.20% | 3.80% | 11.10% | 18.50% | 0.24 |
FSGS | 11.40% | 0% | 5.50% | 33.30% | 0.07 | |
Total | 11.30% | 3.80% | 8.90% | 19.10% | 0.16 | |
Thrombosis | MCD | 7.20% | 3.80% | 7.90% | 9.10% | 0.73 |
FSGS | 2.90% | 0% | 0% | 7.70% | 0.19 | |
Total | 3.30% | 5.60% | 4.80% | 0.95 | ||
Infection | MCD | 26.80% | 23.10% | 31.60% | 29.60% | 0.03 |
FSGS | 13.20% | 33.30% | 3.30% | 19.2 | 0.03 | |
Total | 23.30% | 19.40% | 22.60% | 0.86 | ||
Neoplasia | MCD | 7.70% | 3% | 10.50% | 9.10% | 0.62 |
FSGS | 0% | - | - | - | - | |
Total | 0% | 6.90% | 4.80% | 0.45 | ||
Death | MCD | 4.30% | 0% | 2.60% | 12.10% | 0.07 |
FSGS | 5.90% | 0% | 3% | 11.50% | 0.28 | |
Total | 0% | 2.80% | 11.10% | 0.049 |
FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease.